江苏索普(600746.SH)披露2025年半年度报告，报告期公司实现营收31.58亿元，同比下降1.08%;归属于 上市公司股东的净利润1.02亿元，同比下降13.01%;扣非净利润1.01亿元，同比下降11.02%;基本每股收 益0.0885元。 报告期内，公司主要产品醋酸新增产能较多，竞争加剧，产品价格下跌;主要原材料煤炭价格同比下降; 公司主要产品醋酸产销量增长、成本下降。国内烧碱下游农药、柠檬酸、纺织、印染等行业开工不足， 需求减少，液氯市场持续低迷;硫酸市场原料支撑较强，硫酸价格整体向上。 ...

Group 1 - The company Jiangsu Sopo (600746.SH) announced a plan to issue shares to specific investors, aiming to raise a total of no more than 1.5 billion yuan (including the principal) [1] - The net proceeds from the fundraising, after deducting issuance costs, will be used for the integrated project of vinyl acetate and EVA (Phase I) [1]

Group 1: Resumption of Trading - Jin Chengzi plans to acquire 55% stake in Samit and will resume trading tomorrow; Samit specializes in high-precision fast-reflecting mirror business [1] - Quzhou Development intends to purchase 95.4559% of Xian Dao Electronics and will resume trading tomorrow; Xian Dao focuses on the R&D of sputtering targets and evaporation materials for vacuum coating [1] Group 2: Mergers, Acquisitions, and Capital Increases - China Shipbuilding's dissenting shareholders' acquisition request price is set at 30.02 yuan per share [2] - Jiangsu Suopu plans to raise no more than 1.5 billion yuan through a private placement for the ethylene acetate and EVA integration project (Phase I) [3] - Guangli Microelectronics is acquiring 100% of LUCEDA NV to strategically position itself in silicon photonics technology [4] Group 3: Share Buybacks, Increases, and Equity Transfers - Zhenlei Technology has raised its share buyback price from 38.13 yuan per share to 74 yuan per share [5] - Fuanna has conducted its first buyback of 1 million shares [6] - Shaanxi Jinye plans to repurchase shares worth between 40 million and 70 million yuan, with loans not exceeding 63 million yuan [7] - Donghua Energy's controlling shareholder's concerted action party has received a commitment letter for a special loan to increase holdings, not exceeding 225 million yuan [8] - Taimusi's controlling shareholder intends to transfer 29.99% of the company's shares, with Guangzhou State-owned Assets Supervision and Administration Commission becoming the actual controller [9] Group 4: External Investments and Daily Operations - Haikang obtained the clinical trial approval notice for the innovative drug HSK47977 tablets [10] - Rundou Co., Ltd. received approval for the listing application of glucosamine sulfate sodium chloride compound as a chemical raw material drug [11] - Beilu Pharmaceutical's subsidiary Haichang Pharmaceutical's iodine mepivacaine chemical raw material drug has been approved for listing [12] - Baiyun Airport signed a cooperation contract with China Duty Free Group for the operation of the T3 terminal's outbound duty-free project [13] - Guoshield Quantum plans to sign a sales contract worth 76.5418 million yuan with China Telecom Quantum Group for the sale of quantum key distribution hardware and software [14] Group 5: Performance Changes - Zhenlei Technology's net profit for the first half of 2025 is 62.3197 million yuan, a year-on-year increase of 1006.99%; the company continues to strengthen its advantages in special fields such as data links, electronic countermeasures, wireless communication terminals, next-generation radios, and phased array communications, achieving significant growth in orders and projects [15] - Jingchen Co., Ltd. reported a net profit of 497 million yuan for the first half of the year, a year-on-year increase of 37.12% [16] - China Unicom's net profit for the first half of 2025 is 6.349 billion yuan, a year-on-year increase of 5.1% [17] - Shuanghui Development's net profit for the first half of the year is 2.323 billion yuan, a year-on-year increase of 1.17%; the company plans to distribute 6.5 yuan per 10 shares [18] - Jinlongyu's net profit for the first half of the year is 1.756 billion yuan, a year-on-year increase of 60.07% [19]

江苏索普（SH 600746，收盘价：8.19元）8月12日晚间发布半年度业绩报告称，2025年上半年营业收入 约31.58亿元，同比减少1.08%；归属于上市公司股东的净利润约1.02亿元，同比减少13.01%；基本每股 收益0.0885元，同比减少12.46%。 （文章来源：每日经济新闻） ...

2024年1至12月份，江苏索普的营业收入构成为：化工产品销售占比99.11%，其他业务占比0.89%。 江苏索普（SH 600746，收盘价：8.19元）8月12日晚间发布公告称，公司第十届第十一次董事会会议于 2025年8月12日在公司二楼会议室以现场结合通讯表决方式召开。会议审议了《公司<2025年半年度报 告>全文及摘要》等文件。 （文章来源：每日经济新闻） ...

Core Viewpoint - Jiangsu Sopo announced a plan to issue shares to specific investors, aiming to raise up to 1.5 billion yuan for its integrated acetic acid and EVA project, with a total investment of approximately 3.226 billion yuan [3] Group 1: Financial Performance - For the year 2024, Jiangsu Sopo's revenue composition is as follows: sales of chemical products account for 99.11%, while other businesses account for 0.89% [1] Group 2: Share Issuance Details - The company plans to issue shares to no more than 35 specific investors, with the total number of shares not exceeding 30% of the company's total share capital prior to the issuance, which is approximately 350 million shares [3] - The issuance price will not be lower than 80% of the average stock price over the 20 trading days prior to the pricing benchmark [3] - The funds raised will be specifically allocated to the first phase of the integrated acetic acid and EVA project [3]

格隆汇8月12日丨江苏索普(600746.SH)公布2025年半年度报告，报告期实现营业收入31.58亿元，同比下 降1.08%；归属于上市公司股东的净利润1.02亿元，同比下降13.01%；归属于上市公司股东的扣除非经 常性损益的净利润1亿元，同比下降11.02%；基本每股收益0.0885元。 ...

Group 1 - The core point of the article is that Jiangsu Sopo (600746.SH) announced a plan to issue A-shares to specific investors, with a total fundraising amount not exceeding 1.5 billion yuan, which will be used for the first phase of the integrated project of vinyl acetate and EVA [1] Group 2 - The net proceeds from the fundraising, after deducting issuance costs, will be allocated to the vinyl acetate and EVA integration project [1]

江苏索普化工股份有限公司 关于 2025 年度向特定对象发行 A 股股票预案披露 的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：600746 证券简称：江苏索普 公告编号：临 2025-027 二〇二五年八月十三日 江苏索普化工股份有限公司（以下简称"公司"）于 2025 年 8 月 12 日召开 第十届董事会第十一次会议和第十届监事会第八次会议，审议通过了公司 2025 年度向特定对象发行 A 股股票的相关议案。 《江苏索普化工股份有限公司 2025 年度向特定对象发行 A 股股票预案》（以 下简称"预案"）及相关文件已在上海证券交易所网站（www.sse.com.cn）及《上 海证券报》披露，敬请广大投资者注意查阅。 公司本次向特定对象发行 A 股股票的预案披露事项不代表审核部门对于本 次向特定对象发行股票事项的实质性判断、确认或批准，预案所述本次向特定对 象发行股票相关事项尚需公司股东大会审议通过、上海证券交易所审核通过，并 获得中国证监会作出同意注册的决定后方可实施，敬请广大投资者注意投资风险 ...

证券代码：600746 证券简称：江苏索普 江苏索普化工股份有限公司 2025 年度向特定对象发行 A 股股票预案 2、本次向特定对象发行股票完成后，公司经营与收益的变化，由公司自行 负责；因本次向特定对象发行股票引致的投资风险，由投资者自行负责。 3、本预案是公司董事会对本次向特定对象发行股票的说明，任何与之相反 的声明均属不实陈述。 4、投资者如有任何疑问，应咨询自己的股票经纪人、律师、专业会计师或 者其他专业顾问。 5、本预案所述事项并不代表审批机关对于本次向特定对象发行股票相关事 项的实质性判断、确认、批准或核准，本预案所述本次向特定对象发行股票相关 事项的生效和完成尚待取得有关审批机关的批准。 6、本预案按照《上市公司证券发行注册管理办法》等法规及规范性文件的 要求编制。 1 二〇二五年八月 江苏索普化工股份有限公司 2025 年度向特定对象发行 A 股股票预案 声明 1、公司及董事会全体成员保证本预案内容真实、准确、完整，并确认不存 在虚假记载、误导性陈述或重大遗漏，对预案的真实性、准确性、完整性承担个 别和连带的法律责任。 江苏索普化工股份有限公司 2025 年度向特定对象发行 A 股股票预案 ...